Article PDF
References
Nissen SE, Tuzcu EM, Schoenhagen P, et al, REVERSAL Investigators: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: atherosclerosis: a randomized controlled trial. JAMA 2004; 291: 1071–1080.
Berry C, L'Allier PL, Grégoire J, et al: Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation 2007; 115: 1851–1857.
Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ : Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371–1375.
Nissen SE, Tuzcu EM, Libby P, et al, CAMELOT Investigators: Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004; 292: 2217–2225.
Katayama T, Kubo N, Takagi Y, et al: Relation of atherothrombosis burden and volume detected by intravascular ultrasound to angiographic no-reflow phenomenon during stent implantation in patients with acute myocardial infarction. Am J Cardiol 2006; 97: 301–304.
Iwata A, Miura S, Mori K, Kawahara A, Nishikawa H, Saku K : Associations between metabolic factors and coronary plaque growth or arterial remodeling as assessed by intravascular ultrasound in patients with stable angina. Hypertens Res 2008; 31: 1879–1886.
Arita Y, Kihara S, Ouchi N, et al: Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB–binding protein and regulates growth factor–induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105: 2893–2898.
Wang Y, Lam KS, Xu JY, et al: Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 2005; 280: 18341–18347.
Matsuda M, Shimomura I, Sata M, et al: Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487–37491.
Chen ZP, Mitchelhill KI, Michell BJ, et al: AMP activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 1999; 443: 285–289.
Ouchi N, Kihara S, Arita Y, et al: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–2476.
Hopkins TA, Ouchi N, Shibata R, Walsh K : Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007; 74: 11–18.
Spranger J, Kroke A, Mohlig M, et al: Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226–228.
Lindsay RS, Resnick HE, Zhu J, et al: Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol 2005; 25: e15–e16.
Lawlor DA, Davey Smith G, Ebrahim S, Thompson C, Sattar N : Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005; 90: 5677–5683.
Sattar N, Wannamethee G, Sarwar N, Tchemova J, Cherry L, Wallace AM : Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006; 114: 623–629.
Kistorp C, Faber J, Galatius S, et al: Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005; 112: 1756–1762.
Nakamura T, Funayama H, Kubo N, et al: Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J 2006; 70: 1557–1562.
Wannamethee SG, Whincup PH, Lennon L, Sattar N : Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 2007; 167: 1510–1517.
Menon V, Li L, Wang X, et al: Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2599–2606.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yasu, T. Low Adiponectin Level Causes Vascular Remodeling?: A Perspective through Intravascular Ultrasound. Hypertens Res 31, 2099–2101 (2008). https://doi.org/10.1291/hypres.31.2099
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.2099